Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 24, 2022 12:30 ET | Source: Clarity Clinic

Back to School: Clarity Clinic Psychiatrist Speaks Out On the Child & Adolescent Mental Health Crisis

CHICAGO, Aug. 24, 2022 (GLOBE NEWSWIRE) -- As the summer months come to a close, many young students prepare to head back to school. Although this time can be filled with excitement, the crisis in...
November 12, 2021 08:05 ET | Source: Vallon Pharmaceuticals Inc.

Vallon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update

- Ongoing pivotal intranasal abuse study of lead program, ADAIR, advancing toward completion of patient enrollment and treatment in Q1 2022 - Advancement of second development program, ADMIR, with...
November 01, 2021 08:35 ET | Source: Vallon Pharmaceuticals Inc.

Vallon Pharmaceuticals Presents Data from Adult Stimulant Abuse Pattern Survey at the American Academy of Child and Adolescent Psychiatry (AACAP) 68th Annual Meeting

- Results suggest that developing stimulant formulations with abuse deterrent properties by non-oral routes may potentially reduce negative consequences of misuse, abuse, and diversion of stimulant...
October 24, 2018 08:00 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics to Present New Data for ADHD Medication, Adzenys XR-ODT®, at the American Academy of Child & Adolescent Psychiatry Meeting

DALLAS and FORT WORTH, Texas, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS) today announced that it will present new data for Adzenys XR-ODT (amphetamine) Extended-Release...
October 24, 2017 16:21 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics to Present Two Posters on Company’s ADHD Medications at the American Academy of Child & Adolescent Psychiatry Meeting

DALLAS/FORT WORTH, Texas, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS) today announced that it will present two posters at the 64th Annual Meeting of the American Academy...
October 30, 2015 16:01 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics Presents Data for Investigational ADHD Treatment Cotempla XR-ODT at AACAP's 62nd Annual Meeting

DALLAS/FORT WORTH, Texas, October 30, 2015 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company with three late-stage proprietary, extended release (XR) product...